AHA Coding Clinic® for HCPCS - 2015 Quarter 2; For Your Information
New HCPCS codes for the reporting of drugs and biologicals
Three new HCPCS codes were recently created for the reporting of drugs and biologicals effective July 1, 2015. The new HCPCS codes and their long descriptor are listed in the following table: HCPCS Long Descriptor C9453 Injection, nivolumab, 1 mg C9454 Injection, pasireotide long acting, 1mg C9455 Injection, siltuximab, 10 mg ...
Note: The following article synopsis was NOT provided by the AHA. It was created by Find-A-Code/innoviHealth.
Article Overview
This article reviews recently created HCPCS code additions for drugs and biologicals and notes the effective date for the update. It is relevant to coders, billers, and revenue cycle teams who track HCPCS changes and maintain current reporting references for injectable products.
Why This Topic Matters
Staying current with HCPCS updates helps coding and billing staff recognize new reporting options and align charge capture and claims processes with the latest code set changes.
What You Will Learn
Which HCPCS code update is discussed
When the new reporting changes became effective
Which broad categories of products are covered by the update
Quick, Current, Complete - www.findacode.com